- f
Demographic, clinical and laboratory data of iCCA patients enrolled in the...
- plos.figshare.com
- figshare.com
xlsUpdated May 14, 2025
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCitePongsakorn Martviset; Pathanin Chantree; Nisit Tongsiri; Tullayakorn Plengsuriyakarn; Kesara Na-Bangchang (2025). Demographic, clinical and laboratory data of iCCA patients enrolled in the study. Data are presented as median (interquartile range: IQR) or number (%). [Dataset]. http://doi.org/10.1371/journal.pone.0323732.t001xlsAvailable download formatsUnique identifierhttps://doi.org/10.1371/journal.pone.0323732.t001Dataset updatedMay 14, 2025Dataset provided byPLOS ONEAuthorsPongsakorn Martviset; Pathanin Chantree; Nisit Tongsiri; Tullayakorn Plengsuriyakarn; Kesara Na-BangchangLicenseAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automaticallyDescriptionDemographic, clinical and laboratory data of iCCA patients enrolled in the study. Data are presented as median (interquartile range: IQR) or number (%).
- d
Ranking ICCA Eventos Internacionais , de 2007 a 2016
- data.rio
- hamhanding-dcdev.opendata.arcgis.com
- +1more
Updated Jul 22, 2022ShareFacebookTwitterEmailClick to copy linkLink copiedCitePrefeitura da Cidade do Rio de Janeiro (2022). Ranking ICCA Eventos Internacionais , de 2007 a 2016 [Dataset]. https://www.data.rio/documents/42d874ddf9894d14a500009945df2a93Dataset updatedJul 22, 2022Dataset authored and provided byPrefeitura da Cidade do Rio de JaneiroDescriptionEstudo 3722 Gráficos divulgados pela RIOTUR , com informações prestadas pela ICCA - International Congress and Conference Association.
- Z
Raw Data for the article: Liver transplantation for unresectable...
- data.niaid.nih.gov
Updated Mar 1, 2022ShareFacebookTwitterEmailClick to copy linkLink copiedCiteSalvatore Gruttadauria (2022). Raw Data for the article: Liver transplantation for unresectable intrahepatic cholangiocarcinoma: an Italian experience [Dataset]. https://data.niaid.nih.gov/resources?id=zenodo_6303720Dataset updatedMar 1, 2022Dataset authored and provided bySalvatore GruttadauriaLicenseAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automaticallyDescriptionIntrahepatic cholangiocarcinoma (iCCA) is an aggressive form of primary liver cancer treated exclusively with surgery.
Its incidence in the western world is growing lately [1] and the overall 5-year survival is poor due to late diagnosis, since patients rarely present a jaundice differently from patients affected by perihilar cholangiocarcinoma. Ideally liver resection and regional lymphadenectomy are the best treatments; however, these are unfortunately connotated by a 75% recurrence rate 5 years after surgery. Systemic chemotherapy offers a minimal response, as well as loco-regional therapy such as selective internal radiotherapy (SIRT), with a survival varying from 11 to 15 months between the two therapies
Not seeing a result you expected?
Learn how you can add new datasets to our index.
FacebookTwitterEmailDemographic, clinical and laboratory data of iCCA patients enrolled in the study. Data are presented as median (interquartile range: IQR) or number (%).
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Demographic, clinical and laboratory data of iCCA patients enrolled in the study. Data are presented as median (interquartile range: IQR) or number (%).